September 2023
1. CUMMINGS JL, Osse AML, Kinney JW
   Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification.
   Drugs. 2023 Sep 20. doi: 10.1007/s40265-023-01938.
   

   >> Share

   
   April 2023
2. CUMMINGS J
   Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics.
   Drugs. 2023 Apr 15. doi: 10.1007/s40265-023-01858.
   

   >> Share

   
   March 2023
3. HOY SM
   Lecanemab: First Approval.
   Drugs. 2023;83:359-365.
   

   >> Share

   
   April 2022
4. SCHIFANO F, Catalani V, Sharif S, Napoletano F, et al
   Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.
   Drugs. 2022 Apr 2. pii: 10.1007/s40265-022-01701.
   

   >> Share

   
   August 2021
5. DHILLON S
   Aducanumab: First Approval.
   Drugs. 2021;81:1437-1443.
   

   >> Share

   
   July 2021
6. JI C, Sigurdsson EM
   Current Status of Clinical Trials on Tau Immunotherapies.
   Drugs. 2021;81:1135-1152.
   

   >> Share

   
   March 2020
7. SCOTT LJ
   Lemborexant: First Approval.
   Drugs. 2020;80:425-432.
   

   >> Share

   
   
8. SYED YY
   Sodium Oligomannate: First Approval.
   Drugs. 2020;80:441-444.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share